Skip to main content
Top
Published in: Obesity Surgery 6/2012

01-06-2012 | Clinical Research

Obesity and Inflammation: Change in Adiponectin, C-Reactive Protein, Tumour Necrosis Factor-Alpha and Interleukin-6 After Bariatric Surgery

Authors: Fátima Illán-Gómez, Manuel Gonzálvez-Ortega, Isabel Orea-Soler, Ma. Soledad Alcaraz-Tafalla, Aurora Aragón-Alonso, Mercedes Pascual-Díaz, Matías Pérez-Paredes, Ma. Luisa Lozano-Almela

Published in: Obesity Surgery | Issue 6/2012

Login to get access

Abstract

Background

Obesity is associated with a low-grade inflammatory state. A causal association between inflammation and atherosclerosis has been suggested. The aim of this study was to evaluate changes in the proinflammatory profile of morbidly obese patients after weight loss following bariatric surgery.

Methods

In this study, we measured levels of adiponectin, high-sensitivity C-reactive protein (hs-CRP), tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) and their relation to insulin resistance and lipid parameters in 60 morbidly obese women at baseline and 3, 6 and 12 months after gastric bypass.

Results

Twelve months after surgery, there was a significant increase in plasma levels of adiponectin (p < 0.001) and high-density lipoprotein cholesterol (p < 0.01) and a significant decrease in levels of IL-6 (p < 0.001), hs-CRP (p < 0.001), cholesterol (p < 0.001), triglycerides (p < 0.001), low-density lipoprotein cholesterol (p < 0.001), glucose (p < 0.001), insulin (p < 0.001) and homeostasis model assessment (HOMA; p < 0.001). At 12 months, correlations were seen between IL-6 levels and the following: body mass index (BMI) (r = 0.53, p < 0.001), insulin (r = 0.51, p < 0.001) and HOMA (r = 0.55, p < 0.001). Also, hs-CRP levels correlated with BMI (r = 0.40, p = 0. 004), triglycerides (r = 0.34, p = 0.017), insulin (r = 0.50, p = 0.001) and HOMA (r = 0.46, p = 0.002).

Conclusions

In patients with morbid obesity, significant weight loss is followed by a significant improvement in the inflammatory state, insulin sensitivity and lipid profile. A relationship exists between improved inflammatory profile and insulin sensitivity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wexler Dj, Hu FB, Manson JE. Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. Obes Res. 2005;13:1772–83.PubMedCrossRef Wexler Dj, Hu FB, Manson JE. Mediating effects of inflammatory biomarkers on insulin resistance associated with obesity. Obes Res. 2005;13:1772–83.PubMedCrossRef
2.
go back to reference Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case–control study. Lancet. 2005;366:1640–9.PubMedCrossRef Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27000 participants from 52 countries: a case–control study. Lancet. 2005;366:1640–9.PubMedCrossRef
3.
go back to reference Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–77.PubMedCrossRef Hubert HB, Feinleib M, McNamara PM, et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968–77.PubMedCrossRef
4.
5.
go back to reference Trayhum P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 2005;33:1078–81.CrossRef Trayhum P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans. 2005;33:1078–81.CrossRef
6.
go back to reference Winkler G, Kiss S, Keszthelyi L. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol. 2003;149:129–35.PubMedCrossRef Winkler G, Kiss S, Keszthelyi L. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur J Endocrinol. 2003;149:129–35.PubMedCrossRef
7.
go back to reference Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Inmunol. 2006;6:772–83.CrossRef Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Inmunol. 2006;6:772–83.CrossRef
9.
go back to reference Hager GR, van Haeten TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–71.CrossRef Hager GR, van Haeten TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29:2959–71.CrossRef
10.
go back to reference Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730–7.PubMedCrossRef Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730–7.PubMedCrossRef
11.
go back to reference Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85–9.PubMedCrossRef Kumada M, Kihara S, Sumitsuji S, et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol. 2003;23:85–9.PubMedCrossRef
12.
go back to reference Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731–3.PubMed Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731–3.PubMed
13.
go back to reference Ridker PM, Brown NJ, Vaughan DE. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation. 2004;109(25):IV6–19. Suppl 1.PubMedCrossRef Ridker PM, Brown NJ, Vaughan DE. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation. 2004;109(25):IV6–19. Suppl 1.PubMedCrossRef
14.
15.
go back to reference Sjöström L, Lindroos A, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.PubMedCrossRef Sjöström L, Lindroos A, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93.PubMedCrossRef
16.
go back to reference Scheen AJ, Letiexhe M, Rorive M, et al. Bariatric surgery: 10-year results of the Swedish Obese Subjects Study. Rev Méd Liège. 2005;60(2):121–5.PubMed Scheen AJ, Letiexhe M, Rorive M, et al. Bariatric surgery: 10-year results of the Swedish Obese Subjects Study. Rev Méd Liège. 2005;60(2):121–5.PubMed
17.
go back to reference Sugerman HJ, Wolfe LG, Sica DA. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237(6):751–8.PubMed Sugerman HJ, Wolfe LG, Sica DA. Diabetes and hypertension in severe obesity and effects of gastric bypass-induced weight loss. Ann Surg. 2003;237(6):751–8.PubMed
18.
19.
go back to reference Capella RF, Capella JF. Reducing early technical complications in gastric by-pass surgery. Obes Surg. 1997;7:149–57.PubMedCrossRef Capella RF, Capella JF. Reducing early technical complications in gastric by-pass surgery. Obes Surg. 1997;7:149–57.PubMedCrossRef
20.
go back to reference Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9.PubMedCrossRef Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985;28:412–9.PubMedCrossRef
21.
go back to reference Compher C, Badellino KO. Obesity and inflammation: lessons from bariatric surgery. JPEN. 2008;32:645–7.CrossRef Compher C, Badellino KO. Obesity and inflammation: lessons from bariatric surgery. JPEN. 2008;32:645–7.CrossRef
22.
go back to reference Vazquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90:316–22.PubMedCrossRef Vazquez LA, Pazos F, Berrazueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90:316–22.PubMedCrossRef
23.
go back to reference Vilarrasa N, Vendrell J, Sanchez-Santost R. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-α receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol. 2007;67:679–86.CrossRef Vilarrasa N, Vendrell J, Sanchez-Santost R. Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-α receptors, C-reactive protein and adiponectin in morbidly obese patients. Clin Endocrinol. 2007;67:679–86.CrossRef
24.
go back to reference Forsythe LK, Wallace JMW, Livingstone MBE. Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008;21:117–33.PubMedCrossRef Forsythe LK, Wallace JMW, Livingstone MBE. Obesity and inflammation: the effects of weight loss. Nutr Res Rev. 2008;21:117–33.PubMedCrossRef
25.
go back to reference Butner KL, Nickols-Richardson SM, Clark SF, et al. A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg. 2010;20:559–68.PubMedCrossRef Butner KL, Nickols-Richardson SM, Clark SF, et al. A review of weight loss following Roux-en-Y gastric bypass vs restrictive bariatric surgery: impact on adiponectin and insulin. Obes Surg. 2010;20:559–68.PubMedCrossRef
26.
go back to reference Garcia de la Torre N, Rubio MA, Bordiú E. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab. 2008;93:4276–81.PubMedCrossRef Garcia de la Torre N, Rubio MA, Bordiú E. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab. 2008;93:4276–81.PubMedCrossRef
27.
go back to reference Trakhtenbroit MA, Leichman JG, Algahim MF, et al. Body weight, insulin resistance, and serum adipokine levels two years after two types of bariatric surgery. Am J Med. 2009;122:435–42.PubMedCrossRef Trakhtenbroit MA, Leichman JG, Algahim MF, et al. Body weight, insulin resistance, and serum adipokine levels two years after two types of bariatric surgery. Am J Med. 2009;122:435–42.PubMedCrossRef
28.
go back to reference Swarbrick MM, Stanhope KL, Austrheim-Smith IT, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia. 2008;51:1901–11.PubMedCrossRef Swarbrick MM, Stanhope KL, Austrheim-Smith IT, et al. Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia. 2008;51:1901–11.PubMedCrossRef
29.
go back to reference Dandona P. Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998;83(8):2907–10.PubMedCrossRef Dandona P. Tumor necrosis factor-α in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab. 1998;83(8):2907–10.PubMedCrossRef
30.
go back to reference Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14(5):589–600.PubMedCrossRef Cottam DR, Mattar SG, Barinas-Mitchell E, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14(5):589–600.PubMedCrossRef
31.
go back to reference Kopp H. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23(6):1042–7.PubMedCrossRef Kopp H. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients. Arterioscler Thromb Vasc Biol. 2003;23(6):1042–7.PubMedCrossRef
32.
go back to reference Vazquez LA, Pazos F, Berrezueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90(1):316–22.PubMedCrossRef Vazquez LA, Pazos F, Berrezueta JR, et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab. 2005;90(1):316–22.PubMedCrossRef
33.
go back to reference Appachi S, Kelly KR, Schauer PR, et al. Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from “adiposopathy”. Obes Surg. 2011;21:1928–36.PubMedCrossRef Appachi S, Kelly KR, Schauer PR, et al. Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from “adiposopathy”. Obes Surg. 2011;21:1928–36.PubMedCrossRef
34.
go back to reference Whitson B, Leslie D, Kellogg T, et al. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. J Surg Res. 2007;142(2):295–300.PubMedCrossRef Whitson B, Leslie D, Kellogg T, et al. Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. J Surg Res. 2007;142(2):295–300.PubMedCrossRef
35.
go back to reference Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab. 1997;82:4196–200.PubMedCrossRef Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab. 1997;82:4196–200.PubMedCrossRef
36.
go back to reference Mohamed-Ali V, Goodrick S, Bulmer K, et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol. 1999;277:E971–5.PubMed Mohamed-Ali V, Goodrick S, Bulmer K, et al. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol. 1999;277:E971–5.PubMed
37.
go back to reference Hauner H, Bender M, Haastert B, et al. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord. 1998;22(12):1239–43.PubMedCrossRef Hauner H, Bender M, Haastert B, et al. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int J Obes Relat Metab Disord. 1998;22(12):1239–43.PubMedCrossRef
38.
go back to reference Fernández-Real JM, Broch M, Ricart W, et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor-2 and insulin resistance. Diabetes. 1998;47:1752–62.CrossRef Fernández-Real JM, Broch M, Ricart W, et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor-2 and insulin resistance. Diabetes. 1998;47:1752–62.CrossRef
39.
go back to reference Straczkowski M, Kowalska I, Stepien A. Increased plasma soluble tumor necrosis factor-2 receptor level in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes Cares. 2002;25(10):1824–8.CrossRef Straczkowski M, Kowalska I, Stepien A. Increased plasma soluble tumor necrosis factor-2 receptor level in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes Cares. 2002;25(10):1824–8.CrossRef
40.
go back to reference Bluher M, Kratzsch J, Paschke R. Plasma levels of TNF-α, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diabetes Care. 2001;24:328–34.PubMedCrossRef Bluher M, Kratzsch J, Paschke R. Plasma levels of TNF-α, angiotensin II, growth hormone, and IGF-I are not elevated in insulin-resistant obese individuals with impaired glucose tolerance. Diabetes Care. 2001;24:328–34.PubMedCrossRef
41.
go back to reference Zittermann A. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41(1):105–12.PubMedCrossRef Zittermann A. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol. 2003;41(1):105–12.PubMedCrossRef
42.
go back to reference Bloomberg RD, Fleishman A, Nalle JE, et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg. 2005;15(2):145–54.PubMedCrossRef Bloomberg RD, Fleishman A, Nalle JE, et al. Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg. 2005;15(2):145–54.PubMedCrossRef
43.
go back to reference Kim KY, Kim JK, Han SH, et al. Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol. 2006;176:5958–64.PubMed Kim KY, Kim JK, Han SH, et al. Adiponectin is a negative regulator of NK cell cytotoxicity. J Immunol. 2006;176:5958–64.PubMed
44.
go back to reference Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278:45021–6.PubMedCrossRef Chen H, Montagnani M, Funahashi T, et al. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem. 2003;278:45021–6.PubMedCrossRef
45.
go back to reference Haque WA, Shimomura I, Matsuzawa Y, et al. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002;87:2395.PubMedCrossRef Haque WA, Shimomura I, Matsuzawa Y, et al. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab. 2002;87:2395.PubMedCrossRef
46.
go back to reference Weyer C, Funahashi T. Tanaka S et al Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.PubMedCrossRef Weyer C, Funahashi T. Tanaka S et al Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001;86:1930–5.PubMedCrossRef
47.
go back to reference Cowan GS, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 1998;22:987–92.PubMedCrossRef Cowan GS, Buffington CK. Significant changes in blood pressure, glucose, and lipids with gastric bypass surgery. World J Surg. 1998;22:987–92.PubMedCrossRef
Metadata
Title
Obesity and Inflammation: Change in Adiponectin, C-Reactive Protein, Tumour Necrosis Factor-Alpha and Interleukin-6 After Bariatric Surgery
Authors
Fátima Illán-Gómez
Manuel Gonzálvez-Ortega
Isabel Orea-Soler
Ma. Soledad Alcaraz-Tafalla
Aurora Aragón-Alonso
Mercedes Pascual-Díaz
Matías Pérez-Paredes
Ma. Luisa Lozano-Almela
Publication date
01-06-2012
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 6/2012
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-012-0643-y

Other articles of this Issue 6/2012

Obesity Surgery 6/2012 Go to the issue